← Back to Clinical Trials
Recruiting NCT06867185

NCT06867185 Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Surgical Repair of Digital Nerve Injuries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06867185
Status Recruiting
Phase
Sponsor Checkpoint Surgical Inc.
Condition Digital Nerve Injury
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-04-24
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Brief Electrical Stimulation TherapyDigital Nerve Repair

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-04-24 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical study is to evaluate if a period of electrical stimulation delivered during the surgical repair procedure can speed up nerve healing.

Eligibility Criteria

Inclusion Criteria: * Age 18-80 years * Candidate for surgical intervention under general anesthesia. * Require primary nerve injury repair in at least 1 digital nerve. * Following resection, have a resulting nerve gap of ≤ 10mm. * Able to complete tension-free end-to-end direct repair, or repair with a conduit, autograft, or allograft with a length ≤15mm * Signed and dated informed consent form. Exclusion Criteria: * Severe comorbid conditions, such as arrhythmia or congestive heart failure, preventing surgery under general anesthesia. * Nerve repair occurring \>1 month post-injury. * Incomplete nerve transection. * Injury requiring replantation of target digit * Injury distal to the distal interphalangeal joint. * Injury proximal to branching into the proper or common digital nerves. * Injuries to both digital arteries of an affected digit. * History of neuropathy, diabetic neuropathy, or any other known neuropathy * History of chronic ischemic condition of the upper extremity * Cognitive impairment preventing the ability to provide consent, follow post-operative instructions, or complete clinical assessments.

Contact & Investigator

Central Contact

Director of Clincal Reseach

✉ clinical@checkpointsurgical.com

📞 877-478-9106

Frequently Asked Questions

Who can join the NCT06867185 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Digital Nerve Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06867185 currently recruiting?

Yes, NCT06867185 is actively recruiting participants. Contact the research team at clinical@checkpointsurgical.com for enrollment information.

Where is the NCT06867185 trial being conducted?

This trial is being conducted at Indianapolis, United States, Columbia, United States, St Louis, United States, Columbus, United States and 1 additional location.

Who is sponsoring the NCT06867185 clinical trial?

NCT06867185 is sponsored by Checkpoint Surgical Inc.. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology